Truepill Secures $13.4M Series A Funding to Expand Its 'Amazon for Pharmacy' Vision

VCBeat (WeChat Official Account: vcbeat) has learned that Truepill, a pharmacy services company headquartered in San Mateo, California, announced on the 12th that it had completed a $13.4 million Series A financing round. The round was led by Initialized Capital, with other investors including Y Combinator, Sound Ventures, and Tuesday Capital.

TruePill now serves all 50 U.S. states, including Washington, D.C. Umar Afridi, co-founder and CEO of TruePill, stated that this round of financing will primarily be used to further expand and develop TruePill’s presence in the UK market, as well as to expand and enhance the company’s teams and facilities in the United States.

Afridi stated, “Having worked in retail pharmacies for over 13 years, I have personally witnessed the frustration patients experience with the prescription process and their daily medication needs. To address this issue, we are collaborating with our partners to create an entirely new approach to customer and product experience, making the prescription process faster, more affordable, and more personalized. As a software-driven pharmaceutical company, we are well-positioned to deliver this novel service model to our customers.”

TruePill is a B2B telehealth platform that enables healthcare companies to deliver over-the-counter medications, contraceptives, and other prescription drugs directly to customers’ doorsteps via standard courier services. Afridi describes it as “the Amazon Web Services of the healthcare industry.” TruePill possesses technology that integrates cellular automation with automated technologies. Its API platform provides clients with online pharmacy capabilities, while its highly customized packaging warehouse can process more than 100,000 prescription orders daily.

Nowadays, an increasing number of pharmaceutical companies are beginning to offer medication delivery services. Nurx provides prescription contraceptives and HIV pre-exposure prophylaxis (PrEP) medications through partner pharmacies, while New York and San Francisco-based startups such as ZipDrug, Alto, and Capsule can dispense and deliver most prescription drugs within hours.

Truepill’s B2B model has clearly sparked interest among direct-to-consumer (DTC) brands such as Hims, Hers, and LemonAID, which are now among Truepill’s clients. Sid Viswanathan, President of Truepill and founder of CardMunch, stated that to date, Truepill has processed and dispensed over one million prescriptions.

He added, “Pharmaceutical companies are transforming how consumers interact with prescription medications by continuously introducing innovative products that make prescriptions more accessible, signaling a major shift in healthcare delivery. By providing packaging and fulfillment services to these healthcare pioneers, Truepill will be the company driving this important transformation.”

Truepill was founded by Umar Afridi and Sid Viswanathan in 2016. As a B2B pharmacy services company, it provides medication fulfillment services across all 50 U.S. states through its own facilities. Headquartered in San Mateo, California, Truepill currently employs over 150 people. The company partners directly with D2C consumer brands (such as Hims and Nurx), digital health companies, and other healthcare institutions to deliver routine prescription medications to patients nationwide.

TruePill’s API platform is designed to streamline the prescription process. It enables copay price checks, refill requests, tracking detail retrieval, and status notifications for all orders. The platform also offers customizable packaging and provides customers with comprehensive visibility into the entire pharmacy workflow.

Initialized Capital, founded in 2011 and headquartered in San Francisco, USA, is an early-stage venture capital firm focused on providing initial seed funding to software engineers, designers, and researchers. Initialized Capital currently manages $500 million in assets, has participated in 94 investments, and holds a portfolio of more than 200 companies. Its most recent investment occurred on February 26, 2019, with a $2.5 million seed round in Polis App.

(Compiled by Wang Shuijing)